Rabin Martin, a privately owned company and part of Omnicom PR Group (OPRG), is headquartered in the US. Operating as a business consulting and services firm with approximately 50 employees, it specializes in driving health outcomes, access, and equity, from strategy to execution. The company designs, develops, and delivers solutions aimed at unlocking new markets and opportunities, focusing on increasing access to client medicines and vaccines, and generating stakeholder support. Rabin Martin leverages global health expertise and partnerships, encompassing commercial strategy, health system strengthening, health equity, and therapeutic area expertise across cancer, chronic disease, rare diseases, and maternal and child health. Its approach includes utilizing local market knowledge, policy, and partnerships to impact business and public health outcomes. The firm works with various health entities, including those within the UN, pharmaceutical companies such as J&J and Takeda, and foundations like Rockefeller and Bill & Melinda Gates. It has managed over $2 billion in health programming across 80 markets, including the US, Europe, and Low-to-Middle Income Countries, covering all aspects from strategy and solution development to implementation, measurement, and evaluation.
Subscribe for full access to Rabin Martin's products in full detail 
